
A Step Change in the MenaQ7® Portfolio
Amidst the hustle and bustle of SupplySide West, the Gnosis team was excited to unveil our latest portfolio development – a turnkey immune product designed to bolster one’s foundational health, in a dose form that is meant to seamlessly support the fast-moving, quality-driven consumer. The product is a result of the successful partnership between Gnosis and Probiotcal.
This launch marks a significant milestone in the MenaQ7® journey: introducing a ready-to-market private label finished product. This step change presents brand owners with clear advantages, enabling them to bypass the often-time-consuming development phase and proceed directly to product launch. They can do so with the assurance that they are offering a science backed, branded ingredient in a well-formulated supplement, perfectly positioned for a targeted audience. The launch is a true testament to one of our guiding pillars: Come for K2 Science, Stay for the Partnership.
Gnosis Cocktail Party: A Chance to Re-Connect and Re-Explore
Latest news & videos

- MenaQ7®
- Mobility & Joint
- News
- May 21, 2025
K2SAC’s 4th Meeting Showcases New Clinical Insights and Emerging Talent in Vitamin K2 Research
On May 12-13, the 4th Gnosis Vitamin K2 Scientific Advisory Committee meeting convened leading...

- Adonat®
- Digestion & Gut
- Mobility & Joint
- May 13, 2025
Adonat® Premium SAMe: Your Go-To Brain-Health Solution Through Adulthood
A short, dynamic video dedicated to S-Adenosyl-Methionine benefits, part of a new educational series,...

- News
- Quatrefolic®
- Wellness & Immune
- May 12, 2025
The New Quatrefolic® Liquid Formulation Solution
The global market for liquid dietary supplements is experiencing steady growth, driven by increasing...